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Dr J. Luketich (Pittsburgh, Pa). Dr Wright, that was an excel-
lent presentation, and I congratulate you and your colleagues on
your efforts to utilize the STS database, which includes close to
2000 cases of esophagectomy, to create a model of perioperative
risk. One very important finding of your study, as you point out,
is that thoracic surgeons participating in the STS database have
a markedly lower mortality rate of only 2.5% compared with the
Medicare database showing alarming mortality rates between 8%
and 23%. I have several questions about your study.
What is the quality control of the data collection of the STS data-
base? Are charts periodically audited by the STS during site visits?
Along these lines, has your statistician voiced concerns about includ-
ing the pulmonary function data, with fewer than 40% of patients hav-
ing reported spirometry yet the finding of an overall correlation with
outcome? And I wonder if you could comment specifically on which
morbidities that the lower FEV1 was associated with. And has this
influenced your practice? If you encounter a patient with an FEV1
<60%, are you excluding them from esophagectomy?
Dr Wright (Boston, Mass). Thank you for that question. Cur-
rently, the STS does not audit the data in their database. This is
a new database, in existence for only 6 years. You have to remem-
ber that the cardiac database, in existence for over 15 years, has
only been audited since 3 years ago, I believe. Their initial audit,
I think, was recognized as a success, indicating a less than 10% var-
iation in data elements. We anticipate the same results, but we have
not started that yet. It is clearly something we need to do.
We specifically excluded the use of pulmonary function tests in
our multivariate model because only 40% of our patients had pul-
monary function tests performed. Thus we only did a univariate
analysis of pulmonary function tests. I think that was an honest
way to treat that as we had so much missing data. Certainly, we
encourage surgeons to enter these data, because this is clearly going
to be an important risk factor.
Dr J. Luketich. Thank you. Second question. How serious was
the missing data problem with other variables? And I think you
have answered the other questions about the auditing plans. But
was the rate of missing variables of key comorbidity and outcome
variables of concern?
DrWright. Well, missing variables are always of concern to the
people looking at the database, but I think they were within reason.
For race, age, and gender, there were no missing variables. BMI
was 13%; cigarette smoking, 13%; diabetes, 5%; peripheral vascu-
lar disease, 13%. The rate of missing variables for outcome mea-
sures was<3%.
Dr. Luketich.My final question is in regards to the lack of a vol-
ume/outcome relationship for the number of esophagectomies per-
formed annually in each center. Your analysis included 40 of the 68
sites, and as I understand it, 28 sites performing fewer than 5 esoph-
agectomies per year were excluded from the analysis. I wonder if the
results would be similar if all sites were included? It would seem like
the hospitals with the very lowest numbers of esophagectomies an-
nually are the very hospitals we want to examine when it comes to
low volume of index cases and high complication and death rates.
Did you analyze and correct for other factors such as surgeon vol-
ume and specialty training? And do you think that the requirement
for thoracic board certification and performance of esophagecto-
mies in academic medical centers influence your findings?596 The Journal of Thoracic and Cardiovascular SurgDr Wright. That is an excellent question, a 2-part question. In
answer to the first part, our statisticians thought it was not statisti-
cally valid to include sites that had fewer than 1 esophagectomy per
year, because they were looking on a per-year basis. It would be in-
teresting to go back and see what those results were. But certainly
the sites to the right on my graph show 1 case a year versus 60 cases
a year. There is not a lot of difference.
Certainly I don’t propose that this volume/performance relation-
ship is true of all of America. The STS thoracic database partici-
pants are very select. They belong to the STS, they are board
certified, and they are very interested in quality improvement,
and I think that is why the results are so good.
Dr S. DeMeester (Los Angeles, Calif). Cam, thank you very
much for that interesting presentation and data. Just a quick ques-
tion. Did you analyze induction therapy as either yes or no, they
had it or didn’t have it, or did you stratify by the amount of radia-
tion? As you know, it has been demonstrated that high radiation
doses seem to be associated with the risk of increased morbidity
or mortality.
Dr Wright. That is another good question, and we currently in
our data field only collect radiation as yes or no. So we could not do
that stratification.
Dr J. Benfield (Los Angeles, Calif). Many esophagectomies are
done by general surgeons. Do you see any way to gather meaning-
ful data to compare outcomes of general surgeons with those of tho-
racic surgeons?
Dr Wright. Well, I believe that paper has already been written
by Mark Orringer’s group at the University of Michigan, and they
did show that there was a modest improvement in results if you
were a board-certified thoracic surgeon as opposed to a general
surgeon.
Dr T. Karamlou (Portland, Ore). Two quick questions. One,
what was the conduct of the esophagectomies? Were these transhia-
tal, transthoracic, Ivor-Lewis, laparoscopic, 3 fields? And number
2, how is the diagnosis of some of the comorbidities arrived at, spe-
cifically pneumonia? Was this just a yes/no, or were there strict cri-
teria for establishing this as you used it as one of your composite
end points?
Dr.Wright. Pneumonia is defined in the database. It is a standard
definition of a white count, fever, and a change in sputum. All the
definitions are standardized. We did collect what type of esopha-
gectomy was done, and transhiatal was by far and away the com-
monest esophagectomy performed. But all varieties were looked
at, including Ivor-Lewis and the 3-hole type. We did not stratify
outcome according to esophagectomy type.
Dr N. Altorki (New York, NY). Cam, I enjoyed your presenta-
tion. I was wondering why you did not include in the measure of
morbidity electrical instability, atrial arrhythmias, and this sort. In
our experience, it has been the cause of major morbidity and pro-
longation of the hospital stay, and why was that not entered in
your model?
Dr. Wright. That was a clinical judgment decision in terms of
how major is major. We are aware that atrial fibrillation is a marker
for other bad things happening. Most serious events are respiratory
events, and so we were really focused on pulmonary complications
and morbidity and death after esophagectomy. But I take your point
that it is a judgment call.ery c March 2009
